Showing results (11-20 of 127) with videos related to
Sort By:
Pageof 13
Acta Anaesthesiologica Belgica|January 1, 1994
Clinical variability of possible malignant hyperthermia as revealed by two casesD Bendixen, T D Poulsen, F Knudsen, et al.Clinical Genetics|April 1, 1996
RYR mutation G1021A (Gly341Arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibilityT Fagerlund, H Ording, D Bendixen, et al.Clinical Genetics|March 31, 1998
Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutationT H Fagerlund, H Ording, D Bendixen, et al.Acta Anaesthesiologica Scandinavica|July 1, 1989
Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscleH OrdingAnnales Francaises D'Anesthesie Et De Reanimation|January 1, 1989
Pathophysiology of malignant hyperthermiaH OrdingAnaesthesia|February 15, 2000
Bispectral index monitoring: comparison of two types of electrodeB Thøgersen, H OrdingBritish Journal of Anaesthesia|March 1, 1988
Use of vecuronium and doxapram in patients susceptible to malignant hyperthermiaH Ording, L FonsmarkActa Anaesthesiologica Scandinavica|July 1, 1987
In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine testsH Ording, L T SkovgaardActa Anaesthesiologica Scandinavica|July 1, 1987
In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethoniumH Ording, L T SkovgaardPageof 13